Behavioural and neurochemical sensitization of morphine-withdrawn rats to quinpirole

Pharmacology, Biochemistry, and Behavior
T P PiepponenL Ahtee

Abstract

The sensitivity of dopamine D2-like receptors in morphine-withdrawn rats was studied using the selective agonist quinpirole. Morphine was administered twice daily increasing the daily dose from 20 to 50 mg/kg during 7 days. Twenty-four hours after the last morphine administration the rats were given quinpirole (0.01-1 mg/kg) and their behavior was assessed. Withdrawal from repeated morphine treatment enhanced yawning behavior and penile erections induced by small doses (0.01-0.1 mg/kg) as well as the intensity of stereotypy induced by a large dose (1.0 mg/kg) of quinpirole. In the morphine-withdrawn rats the dose of 1 mg/kg of quinpirole caused less yawning than in the control rats, whereas the number of erections induced by this dose was enhanced as compared with the control animals. In the control rats, the striatal and limbic concentrations of dopamine metabolites, 3,4-dihydroxphenylacetic acid (DOPAC), and homovanillic acid (HVA), were not clearly affected by the smallest dose of quinpirole. However, the small dose of quinpirole (0.01 mg/kg) significantly reduced the levels of DOPAC and HVA in the striatum and limbic forebrain of the rats withdrawn from morphine either for 24 or 48 h. These findings indicate that withdrawal...Continue Reading

References

Mar 14, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·G K Aghajanian, B S Bunney
Jun 18, 1979·Life Sciences·S de la BaumeJ C Schwartz
Sep 1, 1979·Pharmacology, Biochemistry, and Behavior·K R Carlson, J Almasi
Jan 1, 1975·Journal of Neural Transmission·U Strömbom
May 1, 1992·Trends in Pharmacological Sciences·G Di Chiara, R A North
Jan 25, 1991·European Journal of Pharmacology·E AcquasG Di Chiara
Mar 29, 1988·European Journal of Pharmacology·M VasseP Protais
May 1, 1986·Journal of Clinical Periodontology·N W Chilton, J L Fleiss
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jan 21, 1986·European Journal of Pharmacology·G SerraG L Gessa
Jan 1, 1982·Pharmacology, Biochemistry, and Behavior·K R Carlson, T F Seeger
Dec 3, 1984·Life Sciences·J C Stoof, J W Kebabian
Jan 1, 1993·Behavioural Pharmacology·P.W. KalivasM.S. Hooks

Citations

Feb 13, 1999·European Journal of Pharmacology·T P PiepponenL Ahtee
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·K Pietilä, L Ahtee
Sep 10, 2015·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Michael A EmeryShoshana Eitan
Dec 6, 2005·Pharmacology, Biochemistry, and Behavior·Silvina L DiazGraciela N Balerio
Jan 27, 2015·Behavioural Brain Research·Michael A EmeryShoshana Eitan

Related Concepts

Metazoa
Behavior, Animal
Dose-Response Relationship, Drug
Locomotion
Morphine Sulfate (2: 1), Pentahydrate
Nocturnal Penile Tumescence
Withdrawal Symptoms
Rats, Wistar
Quinpirole Hydrochloride
Substance-Related Disorders

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.